Stock Market Reviews

MGTX (MeiraGTx Holdings plc) News

Get the latest news, insights, and market updates on MGTX (MeiraGTx Holdings plc). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson’s Disease
  - This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson’s disease - RMAT designation includes the benefits of the Fast Track and Breakthrough Therapy designations, allows frequent regulatory interactions with the FDA, and potential routes to accelerated approval and Priority Review LONDON and NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinic
  May 9, 2025 - $MGTX
• Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?
  Beam Therapeutics (BEAM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
  Apr 10, 2025 - $MGTX